Pneumococcal Vaccination of Patients with Autoimmune Inflammatory Rheumatic Diseases
Pneumococcal vaccination might prevent the risk of serious pneumococcal infection in patients with autoimmune inflammatory rheumatic diseases (AIIRD). However, a study of the antibody response in patients with AIIRD showed that only 36% achieved a protective antibody level after pneumococcal vaccination.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in